GSDMD and Alzheimer disease: In vivo and in vitro assays also fully demonstrated that Sulfa4/22 could target the cleavage of GSDMD, inhibit the occurrence of pyroptosis and the release of inflammatory factors, exerting a certain effect on the neuroinflammation of AD.